Guozhen Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guozhen Tan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A. Skanderup
Genome Institute of Singapore, Singapore/SG
1 shared publication- Aaron C. Tan
Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
1 shared publication - Amanda O. L. Seet
Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore
1 shared publication - Amit L. Jain
Division of Medical Oncology, National Cancer Centre Singapore, Singapore/SG
1 shared publication - Angela Maria Takano
Department of Anatomical Pathology, Singapore General Hospital, Singapore
1 shared publication - Chipeng Guo
Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication
Latest Publications
- 31 May 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (7) , e23015
UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid
Keloid is a heterogeneous disease featured by the excessive production of extracellular matrix. It is a great challenge for both clinicians and patients regarding the exaggerated and uncontrolled outgrowth and the therapeutic resistance of the disease. In this study, we verified that UCHL1 was drastically upregulated in keloid fibroblasts. UCHL1 had no effects on cell proliferation and migration, but instead promoted collagen I and α‐SMA expression that was inhibited by silencing UCHL1 gene and by adding in LDN‐57444, a pharmacological inhibitor for UCHL1 activity as well. The pathological process was mediated by IGF‐1 promoted Akt/mTOR/HIF‐1α signaling pathway because inhibition of any of them could reduce the expression of collagen I and α‐SMA driven by UCHL1 in fibroblasts. Also, we found that UCHL1 expression in keloid fibroblasts was promoted by M2 macrophages via TGF‐β1. These findings extend our understanding of the pathogenesis of keloid and provide potential therapeutic targets for the disease.
- 31 May 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (7) , e23015
UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid
Keloid is a heterogeneous disease featured by the excessive production of extracellular matrix. It is a great challenge for both clinicians and patients regarding the exaggerated and uncontrolled outgrowth and the therapeutic resistance of the disease. In this study, we verified that UCHL1 was drastically upregulated in keloid fibroblasts. UCHL1 had no effects on cell proliferation and migration, but instead promoted collagen I and α‐SMA expression that was inhibited by silencing UCHL1 gene and by adding in LDN‐57444, a pharmacological inhibitor for UCHL1 activity as well. The pathological process was mediated by IGF‐1 promoted Akt/mTOR/HIF‐1α signaling pathway because inhibition of any of them could reduce the expression of collagen I and α‐SMA driven by UCHL1 in fibroblasts. Also, we found that UCHL1 expression in keloid fibroblasts was promoted by M2 macrophages via TGF‐β1. These findings extend our understanding of the pathogenesis of keloid and provide potential therapeutic targets for the disease.
- 1 March 2021
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (3) , S233
FP14.13 Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)
- 1 March 2021
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (3) , S233
FP14.13 Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)